Literature DB >> 32047764

Resistance of the stable-towards more precise prediction of response to immune checkpoint blockade in microsatellite-unstable cancer patients.

Matthias Kloor1,2.   

Abstract

Entities:  

Year:  2019        PMID： 32047764      PMCID： PMC7011599          DOI： 10.21037/atm.2019.10.29

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  34 in total

1.  Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors.

Authors:  Noralane M Lindor; Lawrence J Burgart; Olga Leontovich; Richard M Goldberg; Julie M Cunningham; Daniel J Sargent; Catherine Walsh-Vockley; Gloria M Petersen; Michael D Walsh; Barbara A Leggett; Joanne P Young; Melissa A Barker; Jeremy R Jass; John Hopper; Steve Gallinger; Bharati Bapat; Mark Redston; Stephen N Thibodeau
Journal:  J Clin Oncol       Date:  2002-02-15       Impact factor: 44.544

Review 2.  MSI/MMR-deficient tumor diagnosis: Which standard for screening and for diagnosis? Diagnostic modalities for the colon and other sites: Differences between tumors.

Authors:  Magali Svrcek; Olivier Lascols; Romain Cohen; Ada Collura; Vincent Jonchère; Jean-François Fléjou; Olivier Buhard; Alex Duval
Journal:  Bull Cancer       Date:  2019-02-01       Impact factor: 1.276

3.  Beta2-microglobulin mutations in microsatellite unstable colorectal tumors.

Authors:  Matthias Kloor; Sara Michel; Boris Buckowitz; Josef Rüschoff; Reinhard Büttner; Elke Holinski-Feder; Wolfgang Dippold; Rudolf Wagner; Mirjam Tariverdian; Axel Benner; Yvette Schwitalle; Beate Kuchenbuch; Magnus von Knebel Doeberitz
Journal:  Int J Cancer       Date:  2007-07-15       Impact factor: 7.396

4.  Impaired HLA Class I Antigen Processing and Presentation as a Mechanism of Acquired Resistance to Immune Checkpoint Inhibitors in Lung Cancer.

Authors:  Scott Gettinger; Jungmin Choi; Katherine Hastings; Anna Truini; Ila Datar; Ryan Sowell; Anna Wurtz; Weilai Dong; Guoping Cai; Mary Ann Melnick; Victor Y Du; Joseph Schlessinger; Sarah B Goldberg; Anne Chiang; Miguel F Sanmamed; Ignacio Melero; Jackeline Agorreta; Luis M Montuenga; Richard Lifton; Soldano Ferrone; Paula Kavathas; David L Rimm; Susan M Kaech; Kurt Schalper; Roy S Herbst; Katerina Politi
Journal:  Cancer Discov       Date:  2017-10-12       Impact factor: 39.397

5.  Major histocompatibility antigens: the human (HLA-A, -B, -C) and murine (H-2K, H-2D) class I molecules.

Authors:  H L Ploegh; H T Orr; J L Strominger
Journal:  Cell       Date:  1981-05       Impact factor: 41.582

6.  Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair-Deficient/Microsatellite Instability-High Metastatic Colorectal Cancer.

Authors:  Michael J Overman; Sara Lonardi; Ka Yeung Mark Wong; Heinz-Josef Lenz; Fabio Gelsomino; Massimo Aglietta; Michael A Morse; Eric Van Cutsem; Ray McDermott; Andrew Hill; Michael B Sawyer; Alain Hendlisz; Bart Neyns; Magali Svrcek; Rebecca A Moss; Jean-Marie Ledeine; Z Alexander Cao; Shital Kamble; Scott Kopetz; Thierry André
Journal:  J Clin Oncol       Date:  2018-01-20       Impact factor: 44.544

7.  T25 repeat in the 3' untranslated region of the CASP2 gene: a sensitive and specific marker for microsatellite instability in colorectal cancer.

Authors:  Peter Findeisen; Matthias Kloor; Sabine Merx; Christian Sutter; Stefan M Woerner; Nicole Dostmann; Axel Benner; Bolormaa Dondog; Michael Pawlita; Wolfgang Dippold; Rudolf Wagner; Johannes Gebert; Magnus von Knebel Doeberitz
Journal:  Cancer Res       Date:  2005-09-15       Impact factor: 12.701

8.  Severe necrotizing myositis associated with long term anti-neoplastic efficacy following nivolumab plus ipilimumab combination therapy.

Authors:  Marie Tauber; Romain Cohen; Pauline Laly; Laurence Josselin; Thierry André; Arsène Mekinian
Journal:  Clin Rheumatol       Date:  2018-11-19       Impact factor: 2.980

9.  Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability.

Authors:  Asad Umar; C Richard Boland; Jonathan P Terdiman; Sapna Syngal; Albert de la Chapelle; Josef Rüschoff; Richard Fishel; Noralane M Lindor; Lawrence J Burgart; Richard Hamelin; Stanley R Hamilton; Robert A Hiatt; Jeremy Jass; Annika Lindblom; Henry T Lynch; Païvi Peltomaki; Scott D Ramsey; Miguel A Rodriguez-Bigas; Hans F A Vasen; Ernest T Hawk; J Carl Barrett; Andrew N Freedman; Sudhir Srivastava
Journal:  J Natl Cancer Inst       Date:  2004-02-18       Impact factor: 13.506

10.  Immune response against frameshift-induced neopeptides in HNPCC patients and healthy HNPCC mutation carriers.

Authors:  Yvette Schwitalle; Matthias Kloor; Susanne Eiermann; Michael Linnebacher; Peter Kienle; Hanns Peter Knaebel; Mirjam Tariverdian; Axel Benner; Magnus von Knebel Doeberitz
Journal:  Gastroenterology       Date:  2008-01-11       Impact factor: 22.682
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.